Butterfly Network, Inc. announced the FDA clearance of its next-generation handheld point-of-care ultrasound system, Butterfly iQ3. The new device is the company?s third iteration of the world?s.
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
Butterfly iQ3 brings unparalleled image quality and new digital imaging modes, iQ Slice and iQ Fan, powered by advanced semiconductor technology for easier, automated image acquisition
Butterfly to Participate at the 26th Annual Needham Growth Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Partnership will bring Butterfly’s Ultrasound-on-Chip to the robotic intervention market, with revenue anticipated from every unit sold upon commercialization